MERCK INITIATES PHASE 3 STUDY EVALUATING OHTUVAYRE® (ENSIFENTRINE) FOR THE PREVENTION OF COPD EXACERBATIONS IN ADULT PATIENTS RECEIVING STANDARD OF CARE WITH A HISTORY OF EXACERBATIONS

Reuters · 4d ago

Please log in to view news